Tuesday, March 5, 2019 Franklin Theater 6:00–7:30 pm Join the Franklin Institute for an important and insightful conversation around the national opioid crisis, and learn some of the innovative ways researchers are hoping to battle it. The Franklin Institute’s Chief Bioscientist Dr. Jayatri Das welcomes Dr. Yasmin Hurd, a prominent neurobiologist Read more…
Has Access to Hepatitis C Virus Therapy Changed for Patients with Mental Health or Substance Use Disorders In The Direct-Acting-Antiviral Period? Direct‐acting antivirals (DAA) for hepatitis C virus (HCV) became available in 2014, but the role of mental health or substance use disorders (MH/SUD) on access to treatment is unknown. Read more…
Hepatitis C Provider Live Webinar Training February 14, 2019 (4:30pm – 5:30pm) Alyson Harty, RN, BSN Clinical Nurse Manager Mount Sinani Institute for Liver Medicine One hour of CME/CNE/CEU credit per webinar – Free for MD, DO, NP, PA, RN clinical providers This is a great opportunity to learn about Read more…
Linkage to care and treatment among patients at an urban health network, Philadelphia, PA A new article in Hepatology details a study that examined the HCV care continuum at five diverse Federally Qualified Health Centers (FQHCs) in Philadelphia between 2012 and 2016 and concluded that: In this U.S. urban setting, Read more…
Hepatitis C Clinical Provider Live Webinar Training January 24, 2019 (4:30pm – 5:30pm) Hosted by Dr. Jeffrey Weiss, PhD Associate Professor, Department of Medicine & Director, REACH Program Division of General Internal Medicine, Icahn School of Medicine One hour of CME/CNE/CEU credit per webinar – Free For MD, DO, NP, Read more…
New Data Mapping the Hepatitis C Epidemic HepVu Webinar Wednesday, Jan. 16, at 2:00 PM Webinar Link Dial-In: 1-701-801-1211 Access code: 506 325 060 On January 16, 2019, HepVu will release its new interactive maps visualizing state-level estimates of people living with Hepatitis C in the U.S. between 2013-2016. HepVu is also releasing maps Read more…
A new study from the American Association for the Study of Liver Diseases reports that over 2 million people in the United States had current HCV infection during 2013‐2016. The findings of the study suggest that the previous 2013-2016 US HCV prevalence estimate derived from NHANES alone underestimates the actual number of HCV Read more…
October is Liver Cancer Awareness Month! We are highlighting resources and events that can help raise liver cancer awareness in populations affected by viral hepatitis. Resources – HepMag’s overview of liver cancer provides basic information on liver cancer, including prevention and available types of treatment. -The HepB Foundation’s Liver Cancer Read more…
October is Liver Cancer Awareness Month! It’s always important to recognize the significant risks of chronic viral hepatitis on long-term health and survival. This month we are highlighting liver cancer, the fastest-growing cause of cancer death in the U.S. The recently published “Effect of Hepatocellular Carcinoma on Mortality Among Individuals Read more…
Coordinated care has the potential to improve access to treatment for individuals with hepatitis C who are naive to direct-acting antivirals; however, having Medicaid could hamper access, according to a recent study published in PLoS ONE. In this study, an integrated treatment team at the Vanderbilt University Medical Center in Tennessee provided care Read more…